|Dr. Ruchi Sharma, Our CEO||Dr. David Hay, Co founder|
Our Founder and CEO, Dr Ruchi Sharma is driven by her passion for taking the benefits of research, and applying them to products and technology in order to make a significant and positive difference in the real world. She is one to watch entrepreneur of 2020 in UK and is leading prestigious grants and multinational partnerships. Dr Sharma obtained a PhD from the world-renowned Roslin Institute at the University of Edinburgh, followed by a post-doctorate in the exciting field of cellular reprogramming at the University of Cambridge. With a firm focus on partnerships and collaboration, Dr Sharma firmly believes that together, we can create a better world. Find out more
|A Professor of Tissue Engineering at the University of Edinburgh, co-Founder and Director Dr David Hay has earned a long-standing reputation for his work in stem cell biology and hepatocyte differentiation. Dr Hay believes that a trans-disciplinary approach is needed to solve the failings that currently exist in the cell microenvironment. Dr Hay with extensive industry network is actively involved in the translation of stem cell derived hepatocytes into scalable manufacturing processes, by defining culture conditions and developing physiologically relevant models. Find out more|
Stemnovate is revolutionising diagnostics and drug discovery through its award-winning platform that offers first in the world complete solution for understanding human genetics and physiological response to medicines.
Stemnovate have patented its technology in the field of organ on chip, DNA synthesis and diagnostic on chip.
Our rapid detection kit for COVID-19 is now available for professional use. Our mission is to make diagnostics accessible and affordable.
Stemnovate is now raising Series A investment for expanding its operations globally.